XL-protein GmbH
XL-proteinAlias
Ticker
—
Listed market
—
Country
Employees (non-consolidated)
—
Related companies
2
§01
Basic information
- Head office
- Germany
- Chief executive
- Employees (non-consolidated)
- Employees (consolidated)
- Start date
- End date
§02
Websites
§03
Business
PASylation® technologycommercializing its ground-breaking PASylation® technologypreclinical as well as clinical development of PASylated proteins in diverse disease areasPASylationHyperactive DNase I modified with XL-protein’s PASylationPASylation technologydesign of proteins with enhanced stabilitycommercializing its ground-breaking PASylation technologypartnerships with international pharmaceutical and biotech companiesdevelopment of biopharmaceuticals with extended half-lifeAvi-PA(S)™ MAb platformpreclinical as well as clinical development of PASylated proteinsPASylated hyperactive DNase I
§04
Related companies
| Company name | Group | Parent | Subsidiary | Customer | Supplier | Alliance | Bank | Shareholder |
|---|---|---|---|---|---|---|---|---|
|
|
||||||||
|
|
Names without a link are companies not yet registered in OpenBizGraph
§05
Network
Drag to move · click to open
§07
News
There is no news.
§09
Sources & updates
DOMAINOwn domain:Yes
UPDATED2026-11-10 01:23 · Model: GPT-6 Luna